Lipid Sciences, Inc. Release: Critical Path Items for Year-End 2007 Highlighted in Presentation at A.G. Edwards’ 2nd Annual Emerging Growth Conference

PLEASANTON, CA--(MARKET WIRE)--Sep 20, 2007 -- Lipid Sciences, Inc. (NasdaqGM:LIPD - News) -- In a presentation made yesterday at the A.G. Edwards’ 2nd Annual Emerging Growth Conference in New York, Dr. S. Lewis Meyer, President and Chief Executive Officer of Lipid Sciences, outlined the timing of critical events for the Company’s HDL Mimetic Peptide Development Program, HDL Selective Delipidation clinical trial, and Viral Immunotherapy platform.